← Leaderboards
Jagan Ayyappan Pillai
Cleveland Clinic Lerner Com-Cwru
$7,065,897
Attributed
$10,077,875
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.7M · FY2017–25$10M$7.5M$5M$2.5M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,204,841 · 9
By mechanism
P30$6,673,534 · 2
RF1$4,924,374 · 1
R01$2,270,781 · 1
R03$964,750 · 3
K23$915,819 · 1
R21$455,583 · 1
Top collaborators
- Gurkan Bebek5 shared
- Debby Wen Tsuang1 shared
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Stephen Mark Rao$16,514,385
- Gurkan Bebek$549,792
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposDementiaS DiseaseBiological MarkersDisease ProgressionCognitivePublic HealthImpaired CognitionNerve DegenerationFutureMild Cognitive ImpairmentMolecularInsightCerebrospinal FluidFoundationsDesignPrecision MedicineBrainPre-ClinicalNeuropathologyMagnetic Resonance ImagingInflammationHeterogeneityNeuroimaging
Grant awards (19)
Assessing Novel Biomarkers for Cognitive Fluctuations in DLB$4,924,374
RF1 · FY2025 · NS · contact PI
Cleveland Alzheimers Disease Research Center$3,062,953
P30 · FY2025 · AG · contact PI
Immune cell activation and associated blood brain barrier changes across different stages of Alzheimer's disease$738,231
R01 · FY2025 · AG · contact PI
Cleveland Alzheimers Disease Research Center$3,064,013
P30 · FY2024 · AG · contact PI
Administrative Core$546,568
P30 · FY2024 · AG · contact PI
Immune cell activation and associated blood brain barrier changes across different stages of Alzheimer's disease$753,300
R01 · FY2023 · AG · contact PI
Immune cell activation and associated blood brain barrier changes across different stages of Alzheimer's disease$779,250
R01 · FY2022 · AG · contact PI
Integrative analysis of proteomics and transcriptomics to delineate vesicular transport related protein abnormalities related to Alzheimer's, Lewy body and mixed Pathologies$455,583
R21 · FY2022 · AG · contact PI
Developing a clinical and research framework for evaluating inflammation pathway dysregulation in Alzheimer's disease$161,000
R03 · FY2022 · AG · contact PI
Integrative analysis of multi-omics data to delineate CCL2 associated inflammatory pathways in Alzheimers Disease$161,000
R03 · FY2022 · AG · contact PI
Inflammatory Networks Mediating Cognitive Decline In Preclinical Alzheimers Disease$173,933
K23 · FY2021 · AG · contact PI
Integrative analysis of multi-omics data to delineate CCL2 associated inflammatory pathways in Alzheimers Disease$161,000
R03 · FY2021 · AG · contact PI
Developing a clinical and research framework for evaluating inflammation pathway dysregulation in Alzheimer's disease$161,000
R03 · FY2021 · AG · contact PI
Inflammatory Networks Mediating Cognitive Decline In Preclinical Alzheimers Disease$182,853
K23 · FY2020 · AG · contact PI
Pyroglutamate-modified Amyloid-B protein as a marker for future cognitive decline in preclinical AlzheimerÂs disease$160,750
R03 · FY2020 · AG · contact PI
Inflammatory Networks Mediating Cognitive Decline In Preclinical Alzheimers Disease$184,304
K23 · FY2019 · AG · contact PI
Pyroglutamate-modified Amyloid-B protein as a marker for future cognitive decline in preclinical AlzheimerÂs disease$160,000
R03 · FY2019 · AG · contact PI
Inflammatory Networks Mediating Cognitive Decline In Preclinical Alzheimers Disease$187,625
K23 · FY2018 · AG · contact PI
Inflammatory Networks Mediating Cognitive Decline In Preclinical Alzheimers Disease$187,104
K23 · FY2017 · AG · contact PI